w/PARD ($2.13-nasdaq) you have the 2010 ASCO GI Symposium on Saturday (Jan 24th) where they will be presenting Phase II data in CRC. http://www.asco.org/ASCOv2/Meetings/Gastrointestinal+Cancers+Symposium images.investorshub.advfn.com/images/uploads/2010/1/21/zctmlPARD_on_Biomed_Calendar.JPG images.investorshub.advfn.com/images/uploads/2010/1/21/gotxhASCO_2010_GI_Symposium.JPG